Emcure Pharmaceuticals
Founded Year
1983Stage
Private Equity - II | AliveTotal Raised
$150MValuation
$0000Last Raised
$100M | 10 yrs agoAbout Emcure Pharmaceuticals
Emcure Pharmaceuticals is a fast growing Indian pharmaceutical company engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally. The company's core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which it commercializes through it's marketing infrastructure across geographies and relationships with multi-national pharmaceutical companies.
Missing: Emcure Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Emcure Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Emcure Pharmaceuticals
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Emcure Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Emcure Pharmaceuticals Patents
Emcure Pharmaceuticals has filed 31 patents.
The 3 most popular patent topics include:
- Antineoplastic drugs
- Organochlorides
- Alkylating antineoplastic agents

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
1/3/2018 | 9/1/2020 | Cardiac arrhythmia, Ketones, Amines, TAAR1 agonists, Phenols | Grant |
Application Date | 1/3/2018 |
---|---|
Grant Date | 9/1/2020 |
Title | |
Related Topics | Cardiac arrhythmia, Ketones, Amines, TAAR1 agonists, Phenols |
Status | Grant |
Latest Emcure Pharmaceuticals News
Jan 20, 2023
News Provided By Share This Article Hodgkins Lymphoma Treatment Market BURLINGAME, CALIFORNIA, UNITED STATES, January 20, 2023 / EINPresswire.com / -- The primary trends in the global Hodgkins Lymphoma Treatment industry are the focus of Hodgkins Lymphoma Treatment Market research. Future projections for the sector have also been looked into, along with the current Industry scenario. The market analysis report evaluates a number of important variables, including an industry overview, key manufacturers, product/service application and type, important geographic markets, and forecast estimates for CAGR, revenue, and market share on a global scale. Lymphoma is a type of cancer that develops in the body's lymphocytes, or white blood cells. It is classified into two types: Hodgkin's Lymphoma and Non-Lymphoma. Hodgkin's Hodgkin's lymphoma is classified into two types: classic and nodular lymphocyte predominant. Fever, sudden weight loss, and swollen lymph nodes are some of the symptoms of Hodgkin's Lymphoma in the body. Hodgkin's lymphoma is typically treated with chemotherapy alone or in conjunction with radiotherapy. ???????? ???????????? ???????????????? ???????????????????????????????? ???????????????????????????????????????? ???????????????????????????? ???????????? ???????????????????????? ???????????????? @ https://www.coherentmarketinsights.com/insight/request-sample/2658 ???????????? ???????????????????????? ???????????????????????????????????????????????? ???????????????? ???????????? ???????????????????????? ???????????????? ???????? ???????????????????????????? ???????????? ???????????????????????????????? ???????????????? ???????????????? ???????? ???????????????? ???????????????? ???????????????????????????????????????????????????? ???????????????????????????????????????????? ???????????????? ???????????????????????????????? ???????????????? ???????????????? ???????????????? ???????????????? ???????? ???????????? ????????????????????????????????????????. • Important market participants. • User applications • Overall growth forecast of Market. ???????????????????? ???????????????????????????? ???????? ???????????????? ???????????????????????? ????????????: Emcure Pharmaceuticals Pvt. Ltd., Aspen Global Inc., Pfizer Inc., Ono Pharmaceuticals Co. Ltd., Corden Pharma Latina SPA, Horizon Pharma USA Inc., Cipla Ltd., Lediant Biosciences Inc., Jansenn Research and Development LLC, and Merck & Co., Inc. What To Expect From This Report On Hodgkins Lymphoma Treatment Market • When you have knowledge of the value of production, cost of production, value of the products, and more for the next five years, you may build development strategies for your company. • A thorough rundown of regional distributions and the main categories of selling goods. • How do the market's big businesses and mid-level producers turn a profit? • Calculate how much it will cost new players to break into the market. • Researching the overall growth of the keyword market in-depth will help you determine whether to launch a product and when to create assets. ???????????????????????????????? ???????????????? ???????????????????????????? ???????????????????????? ???????????????? ???????? ???????? ????????% ???????????? @ https://www.coherentmarketinsights.com/insight/buy-now/2658 Detailed Segmentation: The global Hodgkin’s lymphoma treatment market is segmented on the basis of treatment type, route of administration, distribution channel, and regions. By Treatment Type The Global Hodgkins Lymphoma Treatment Market Industry Report Covers The Following Data Points: ???????????????????????????? ????: This section provides an overview of the global market, including a general market introduction and market analysis by type, region, and application. North America, Europe, Asia-Pacific, the Middle East, and Africa are the principal geographical regions of the worldwide market industry. This section presents industry statistics and forecasts for the years 2023 to 2030. Market dynamics explains the potential, major forces at work, and market risk. ???????????????????????????? ????: The market manufacturers profile in this area is broken down by business overview, product type, and application. Each company is detailed in this research along with their sales volume, market product price, gross margin analysis, and market share. ???????????????????????????? ???? ???????????? ???????????????????????????? ????: Based on each manufacturer's sales, profitability, and market share, these sections outline the market competitiveness. Additionally, it discusses the industry scenario depending on local circumstances. ???????????????????????????? ???? ???????????? ???????????????????????????? ????: For each region, forecast data for the keyword market (2023–2030) is provided in these parts. This research presents the development trends as well as the sales channels, which include traders, distributors, and direct and indirect marketing. ???????????????????????????? ???? ???????????? ???????????????????????????? ????: These parts address the important research findings and conclusions for the industry, analysis methodology, and data sources. In this study, the years considered to estimate the market size of Hodgkins Lymphoma Treatment market are as follows: – ???????????????????????????? ????????????????: ????????????????-???????????????? ???????????????????????????? ???????? ???????????????????????????????? ???????????????? ???????????????????????? • Current and future of global Hodgkins Lymphoma Treatment market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players ???????????????????????????????? ???????????????? ???????????????????????????? ???????????????????????? ???????????????? ???????? ???????? ????????% ???????????? @ https://www.coherentmarketinsights.com/insight/buy-now/2658 Keep tabs on and assess market competition by keeping track of joint ventures, alliances, mergers, and acquisitions, new product developments, and research and developments. Data is displayed in graphical and table formats to more succinctly clarify the concepts. By looking at the reviews left by several industry professionals, the needs of the customers are gathered. About Coherent Market Insights Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Mr. Shah +1 206-701-6702
Emcure Pharmaceuticals Frequently Asked Questions (FAQ)
When was Emcure Pharmaceuticals founded?
Emcure Pharmaceuticals was founded in 1983.
Where is Emcure Pharmaceuticals's headquarters?
Emcure Pharmaceuticals's headquarters is located at Emcure House, Pune.
What is Emcure Pharmaceuticals's latest funding round?
Emcure Pharmaceuticals's latest funding round is Private Equity - II.
How much did Emcure Pharmaceuticals raise?
Emcure Pharmaceuticals raised a total of $150M.
Who are the investors of Emcure Pharmaceuticals?
Investors of Emcure Pharmaceuticals include Bain Capital and Blackstone.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.